Precision Biologics, Inc.

Other

Neogenix Oncology, Inc.

Xue-Ping Wang

Philip M Arlen

Judith A Kantor

J Andrew Bristol

Andrew Bristol

Mark H Kaplan

Xiulian Du

Janos Luka

Lewis Joe Stafford

Mark Semenuk

Michael H Dosik

The invention relates to a peptidomimetic of an NPC-1 epitope on the MUC5AC protein which is differentially expressed in pancreatic and colorectal cancer, and diagnostic and therapeutic usages. Further, antibodies that selectively bind the NPC-1 epitope peptidomimetics and may be used in diagnostic and therapeutic methods.

Colon and pancreas cancer peptidomimetics

This invention relates to humanized antibodies that selectively bind the 31.1 epitope on the A33 protein differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages.

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

This invention relates to NPC-1 antigen on the MUC5AC protein and 16C3 antigen on CEACAM5 and CEACAM6 proteins, and 31.1 epitope on the A33 protein are differentially expressed in cancers including, lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer, and diagnostic and therapeutic usages. Further, NPC-1, 16C3, and/or 31.1 epitope specific antibodies and diagnostic and therapeutic methods of use.

Colon and pancreas cancer specific antigens and antibodies

ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alu. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.

ELF3 gene compositions and methods

Growing community of inventors

Port Washington, NY, United States of America

Xue-Ping Wang